Close

News

Innovent phase 3 ORIENT-32 trial of Tyvyt in combo with Byvasda to treat advanced hepatocellular carcinoma meets primary endpoints

Innovent Biologics, a biopharmaceutical company, announced the results of a phase 3, open label, randomized study in China. The ORIENT-32 trial evaluating Tyvyt (sintilimab injection) in combination with Byvasda (bevacizumab biosimilar injection, or IBI305) as a first-line treatment in...

CPhI Pharma Index: Italy and India the only pharma economies to improve score in 2020

Ahead of the CPhI Festival of Pharma (5-16 October, 2020) – global pharma’s largest ever virtual gathering – the CPhI Pharma Index shows only Italy and India have improved their score in 2020, with the majority of industry executives...

Anti-influenza drug Avigan Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients

FUJIFILM Toyama Chemical Co., Ltd. has announced that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” conducted in Japan for patients with novel coronavirus infections (hereinafter “COVID-19”). The efficacy primary endpoint is time to...

UDG Healthcare Appoints New COO

UDG Healthcare plc, a leading international healthcare services provider, has appointed Ryan Quigley as Chief Operating Officer (COO). Based in UDG’s headquarters in Dublin, Ireland, Ryan will join the UDG Senior Executive Team and take responsibility for establishing and delivering...

Sterling Pharma Solutions launches £11 million Material Science Centre

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last year. The three-floor MSC comprises six ISO Class 8 cleanrooms, which house four milling and...

LANXESS India wins prestigious awards from Indian Chemical Council

Specialty chemicals company LANXESS India has received multiple awards from the Indian Chemical Council (ICC), recognizing the organization’s commitment and outstanding performance specifically in the areas of Environment and Human Resource Management under the ‘Large Companies’ category. It also...

Clinical Trial of Ayurvedic Remedy For COVID-19 Shows Groundbreaking Results

A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines. The interim report on combination treatment of an Ayurvedic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »